These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28029011)

  • 1. Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines.
    Kim S; Yun YM; Chae HJ; Cho HJ; Ji M; Kim IS; Wee KA; Lee W; Song SH; Woo HI; Lee SY; Chun S
    Ann Lab Med; 2017 Mar; 37(2):180-193. PubMed ID: 28029011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention.
    Dong OM; Wheeler SB; Cruden G; Lee CR; Voora D; Dusetzina SB; Wiltshire T
    Value Health; 2020 Jan; 23(1):61-73. PubMed ID: 31952675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?
    Solomon HV; Cates KW; Li KJ
    Psychiatry Res; 2019 Jan; 271():604-613. PubMed ID: 30554109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals.
    Wang Y; Xiao F; Chen Y; Xiao LD; Wang LY; Zhan Y; Xiong XL; Zhou G; Liu R; Ouyang DS; Li Z; McLeod HL; Zhang W; Li Q; Liu ZQ; Zhou HH; Yin JY
    Clin Transl Med; 2021 Nov; 11(11):e586. PubMed ID: 34841710
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative Project.
    Pratt VM; Turner A; Broeckel U; Dawson DB; Gaedigk A; Lynnes TC; Medeiros EB; Moyer AM; Requesens D; Vetrini F; Kalman LV
    J Mol Diagn; 2021 Aug; 23(8):952-958. PubMed ID: 34020041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?
    Shahin MH; Johnson JA
    Curr Opin Cardiol; 2013 May; 28(3):305-14. PubMed ID: 23478884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype and phenotype concordance for pharmacogenetic tests through proficiency survey testing.
    Wu AH
    Arch Pathol Lab Med; 2013 Sep; 137(9):1232-6. PubMed ID: 23991737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics and cardiovascular disease--implications for personalized medicine.
    Johnson JA; Cavallari LH
    Pharmacol Rev; 2013 Jul; 65(3):987-1009. PubMed ID: 23686351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CYP2C19 genotype testing in clinical use of clopidogrel: is it really useful?
    Zeb I; Krim N; Bella J
    Expert Rev Cardiovasc Ther; 2018 May; 16(5):369-377. PubMed ID: 29589775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification.
    Baltzer Houlind M; Hansen L; Iversen E; Rasmussen HB; Larsen JB; Jørgensen S; Dalhoff K; Damkier P; Walls AB; Vermehren C; Andersen TRH; Kallemose T; Christrup L; Westergaard N
    Basic Clin Pharmacol Toxicol; 2024 May; 134(5):756-763. PubMed ID: 38403838
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.
    Dorji PW; Wangchuk S; Boonprasert K; Tarasuk M; Na-Bangchang K
    Drug Metab Pers Ther; 2019 Dec; 34(4):. PubMed ID: 32004143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of oral antiplatelet drugs.
    Yasmina A; de Boer A; Klungel OH; Deneer VH
    Pharmacogenomics; 2014 Mar; 15(4):509-28. PubMed ID: 24624918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese Patients With Heart Valve Replacement Do Not Benefit From Warfarin Pharmacogenetic Testing on Anticoagulation Outcomes.
    Hao Y; Yang J; Zheng X; Hu Y; Yan X; Zhang L
    Ther Drug Monit; 2019 Dec; 41(6):748-754. PubMed ID: 31259883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
    Donohue MM; Tirschwell DL
    Curr Neurol Neurosci Rep; 2011 Feb; 11(1):52-60. PubMed ID: 21046289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of cardiovascular pharmacogenetics.
    Voora D; Ginsburg GS
    J Am Coll Cardiol; 2012 Jul; 60(1):9-20. PubMed ID: 22742397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacogenomics of warfarin and clopidogrel.
    Shin J
    J Pharm Pract; 2012 Aug; 25(4):428-38. PubMed ID: 22674970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment.
    Ingelman-Sundberg M; Pirmohamed M
    J Intern Med; 2024 May; 295(5):583-598. PubMed ID: 38343077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel and CYP2C19: pharmacogenetic testing ready for clinical prime time?
    Knauer MJ; Diamandis EP; Hulot JS; Kim RB; So DY
    Clin Chem; 2015 Oct; 61(10):1235-40. PubMed ID: 26272232
    [No Abstract]   [Full Text] [Related]  

  • 19. Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.
    Bousman CA; Jaksa P; Pantelis C
    Pharmacogenet Genomics; 2017 Nov; 27(11):387-393. PubMed ID: 28777243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.